Alternatives to Dio Tree

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered blood test for early cancer detection and subtyping.

Biotechnology company developing novel therapies for multiple myeloma.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Compressing biology to develop the next generation of therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

CBX Therapeutics is a biotechnology company focused on developing novel therapies for cancer.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Developing novel therapeutics for rare genetic diseases.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Omnix Medical is developing a novel platform for advanced wound care management.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

AI-powered insights platform for life sciences and biotech workflows.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Cell and gene therapy company developing biological vehicles for CNS delivery.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Prophet Bio is a biotech startup focused on developing novel therapeutics for neurodegenerative diseases.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Cloud-based platform for reproducible computational research in life sciences.

Developing polymer-based nanoparticles for targeted gene therapy delivery.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Developing novel nitroxide-based therapeutics to treat inflammatory lung diseases.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

AI-guided drug discovery platform for tissue-targeted medicines.

AI-driven drug discovery platform accelerating breakthrough scientific research.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.

AI-powered platform for designing novel molecular structures for new medicines.

Developing engineered biologics to harness the immune system for disease treatment.

Bio-pharmaceutical company developing novel, biologically sourced therapies for animal and human health.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Developing novel suprachoroidal delivery technology for targeted, rapid, and durable retinal disease treatments.